Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years

featured-image

Krystal Biotech (NASDAQ:KRYS) has outperformed the market over the past 5 years by 15.4% on an annualized basis producing an average annual return of 29.66%. Currently, Krystal Biotech has a market capitalization of $4.89 billion. Buying $100 In KRYS: If ...Full story available on Benzinga.com

Krystal Biotech KRYS has outperformed the market over the past 5 years by 15.4% on an annualized basis producing an average annual return of 29.66%.

Currently, Krystal Biotech has a market capitalization of $4.89 billion. Buying $100 In KRYS: If an investor had bought $100 of KRYS stock 5 years ago, it would be worth $359.



67 today based on a price of $169.73 for KRYS at the time of writing. Krystal Biotech's Performance Over Last 5 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor. Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock – anytime. © 2025 Benzinga.

com. Benzinga does not provide investment advice. All rights reserved.

.